Non of the above. The drug worked only in the sickest patient in the study, and those patients performed 16% better than the PBO arm
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-6
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.8¢ |
Change
0.038(8.52%) |
Mkt cap ! $262.7M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 48.0¢ | 44.0¢ | $1.239M | 2.654M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 6279 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 70670 | 9 |
View Market Depth
| Last trade - 13.55pm 10/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |